Terms: = Lymphoma AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Prognosis
68 results:
1. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP.
Zhan Z; Guo W; Wan X; Wang B; Li J; Wang H; Li Z; Huang Y; Young KH; Bai O
Front Immunol; 2024; 15():1324113. PubMed ID: 38318173
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical and molecular biological characterization of patients with accelerated chronic lymphocytic leukemia].
Zhou ZY; Dai LMJ; Sha YQ; Qiu TL; Qin SC; Miao Y; Xia Y; Wu W; Tang HN; Xu W; Li JY; Zhu HY
Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):917-923. PubMed ID: 38185521
[No Abstract] [Full Text] [Related]
3. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
4. Higher 13-Gene-Estimated TMB Detected from Plasma ctDNA is Associated with Worse Outcome for T-Cell lymphoma Patients.
Chen C; Huang L; Chen Z; Ou Q; Liu S; Jiang X; Chen F; Wei X; Guo H; Shao Y; Zeng C; Li Y; Li W
Adv Biol (Weinh); 2023 Dec; 7(12):e2300042. PubMed ID: 37658484
[TBL] [Abstract] [Full Text] [Related]
5. [Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma].
Wang Y; Shi ZY; Shi Q; Wang S; Zhang MC; Shen R; He Y; Qiu HL; Yi HM; Dong L; Wang L; Cheng S; Xu PP; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):321-327. PubMed ID: 37357002
[No Abstract] [Full Text] [Related]
6. Comprehensive FISH testing using FFPE tissue microarray of primary lymph node tissue identifies secondary cytogenetic abnormalities in Mantle Cell lymphoma.
Webb F; Morey A; Mahler-Hinder C; Georgousopoulou E; Koo R; Pati N; Talaulikar D
Cancer Genet; 2023 Jun; 274-275():75-83. PubMed ID: 37094546
[TBL] [Abstract] [Full Text] [Related]
7. Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing.
Hou Y; Zi J; Liu S; Ge Q; Ge Z
Mol Carcinog; 2023 Feb; 62(2):200-209. PubMed ID: 36300887
[TBL] [Abstract] [Full Text] [Related]
8. Hypomethylation and the Resultant Overexpressed PARM1: a Biomarker for Poor prognosis of Diffuse Large B-cell lymphoma.
Cao B; Guo X; Wang B; Wang W; Han D; Zhang W; Zhong K
Discov Med; 2022; 33(168):27-40. PubMed ID: 36274211
[TBL] [Abstract] [Full Text] [Related]
9. Targeted sequencing reveals the relationship between mutations and patients' clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma.
Ma G; Gao Y; Jing X; He C; Liu H; Wu X; Gao Z; Li Y; Zhang S; Zhao G
Leuk Lymphoma; 2023 Jan; 64(1):140-150. PubMed ID: 36215154
[TBL] [Abstract] [Full Text] [Related]
10. Dynamics of minimal residual disease defines a novel risk-classification and the role of allo-HSCT in adult Ph-negative B-cell acute lymphoblastic leukemia.
Cai Z; Liu Y; Tang B; Wu Z; Wang Z; Lin R; Xu X; Huang Z; Ou J; Li X; Liu X; Liu Q; Zhou H
Leuk Lymphoma; 2022 Dec; 63(13):3181-3190. PubMed ID: 36098226
[TBL] [Abstract] [Full Text] [Related]
11. Does early disease progression predict survival after first line-treatment of Waldenström macroglobulinemia?
Labreuche J; Assouan D; Durot E; Tomowiak C; Roos-Weil D; Toussaint E; Bijou F; Lemal R; Brion A; Laribi K; Ysebaert L; Duhamel A; Morel P;
Hematol Oncol; 2022 Aug; 40(3):400-408. PubMed ID: 35385885
[TBL] [Abstract] [Full Text] [Related]
12. EBV-Positive Plasmacytomas Involving a Nasopharyngeal Angiofibroma in an Adolescent.
Mariani R; King RL; Liu H
Pediatr Dev Pathol; 2021; 24(3):264-268. PubMed ID: 33683983
[TBL] [Abstract] [Full Text] [Related]
13. IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.
Nadeu F; Royo R; Clot G; Duran-Ferrer M; Navarro A; Martín S; Lu J; Zenz T; Baumann T; Jares P; Puente XS; Martín-Subero JI; Delgado J; Campo E
Blood; 2021 May; 137(21):2935-2946. PubMed ID: 33211804
[TBL] [Abstract] [Full Text] [Related]
14. Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis.
Hill HA; Qi X; Jain P; Nomie K; Wang Y; Zhou S; Wang ML
Blood Adv; 2020 Jul; 4(13):2927-2938. PubMed ID: 32598477
[TBL] [Abstract] [Full Text] [Related]
15. [The prognostic significance of POD24 in 106 cases with splenic marginal lymphoma with bone marrow invasion].
Lyu R; Yan YT; Yi SH; Wang TY; Deng SH; Liu W; Huang WY; An G; Sui WW; Zou DH; Qiu LG; Li ZJ
Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):228-233. PubMed ID: 32311893
[No Abstract] [Full Text] [Related]
16. Abnormal expression of p-atm/CHK2 in nasal extranodal NK/T cell lymphoma, nasal type, is correlated with poor prognosis.
Ye Q; Chen H; Wen Z; Guo W; Huang Y; Mo X
J Clin Pathol; 2021 Apr; 74(4):223-227. PubMed ID: 32220941
[TBL] [Abstract] [Full Text] [Related]
17. Molecular characterization of sorted malignant B cells from patients clinically identified with mantle cell lymphoma.
Hansen MH; Cédile O; Blum MK; Hansen SV; Ebbesen LH; Bentzen HHN; Thomassen M; Kruse TA; Kavan S; Kjeldsen E; Kristensen TK; Haaber J; Abildgaard N; Nyvold CG
Exp Hematol; 2020 Apr; 84():7-18.e12. PubMed ID: 32173361
[TBL] [Abstract] [Full Text] [Related]
18. Somatic
Foy A; McMullin MF
J Clin Pathol; 2019 Nov; 72(11):778-782. PubMed ID: 31473630
[TBL] [Abstract] [Full Text] [Related]
19. Factors affecting survival in patients with endobronchial malignant mass after flexible Bronchoscopic cryotherapy: a cohort study.
Chung FT; Chou CL; Lo YL; Kuo CH; Wang TY; Wang CH; Huang HY; Lin HC; Chang CH; Lee CS; Chen HC; Lin SM
BMC Pulm Med; 2019 May; 19(1):101. PubMed ID: 31126271
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of SKP2 Activity Impaired atm-Mediated DNA Repair and Enhanced Sensitivity of Cisplatin-Resistant Mantle Cell lymphoma Cells.
Yan W; Yang Y; Yang W
Cancer Biother Radiopharm; 2019 Sep; 34(7):451-458. PubMed ID: 31025879
[No Abstract] [Full Text] [Related]
[Next]